Regeneron’s COVID-19 treatment gets emergency approval from FDA

November 21, 2020 | 9:16pm Enlarge Image Regeneron Pharmaceuticals campus in Tarrytown, New York. REUTERS The U.S. Food and Drug Administration has given the green light for emergency use of Regeneron’s COVID-19 antibody drug — the same treatment given to President Trump. The treatment is aimed at those with mild cases of COVID-19, and not…Continue Reading